BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Boston Therapeutics, Inc. 

1750 Elm Street, Suite 103

Manchester  New Hampshire  03104  U.S.A.
Phone: 603-935-9799 Fax: 603-685-4784


SEARCH JOBS




Industry
Pharmaceutical






 Company News
Boston Therapeutics, Inc. Completes Enrollment Of Patients With Type 2 Diabetes In Phase IIb Study On BTI-320 In The U.S. 8/20/2014 10:13:25 AM
Boston Therapeutics, Inc. Appoints Noted Diabetes Specialist Jaime A. Davidson, M.D. To Its Medical Advisory Board 8/18/2014 9:43:22 AM
Boston Therapeutics, Inc. Expands Medical Advisory Board 8/6/2014 11:07:08 AM
Boston Therapeutics, Inc. To Sponsor Symposium At American Chemical Society's Fall National Meeting In San Francisco 8/1/2014 11:14:47 AM
Boston Therapeutics, Inc. Appoints Zbigniew J. Witczak, Ph.D., To Its Scientific Advisory Board 7/29/2014 11:49:39 AM
Boston Therapeutics, Inc. Appoints Benjamin Rivnay, Ph.D. To Chief Scientist 7/9/2014 11:28:56 AM
Boston Therapeutics, Inc. Initiates Phase 2b Study To Assess The Efficacy And Safety Of SUGARDOWN® For Type 2 Diabetes 5/29/2014 10:18:01 AM
Boston Therapeutics, Inc. To Present At SeeThruEquity Microcap Investor Conference On May 28 And Marcum Microcap Conference On May 29 5/28/2014 11:11:47 AM
Boston Therapeutics, Inc. Announces Strategic Marketing Agreement With Benchworks SD Aimed At Growing Sales Of SUGARDOWN® 5/20/2014 9:35:02 AM
Boston Therapeutics, Inc. Reports Corporate Update and Financial Results For The First Quarter Ended March 31, 2014 5/14/2014 9:39:02 AM
123456